Cardiophrenic lymph nodes in advanced ovarian cancer

被引:3
|
作者
Agusti, Nuria [1 ]
Bonaldo, Giulio [2 ]
Kahn, Ryan M. [3 ]
Rosati, Andrea [4 ]
Nachira, Dania [5 ]
Pan, Teresa L. [6 ]
Mburu, Anisa [7 ]
Kochiashvili, Gvantsa [8 ,9 ]
Paredes, Pilar [10 ]
Hsu, Heng-Cheng [11 ]
Davies-Oliveira, Jennifer [12 ]
Ramirez, Pedro T. [13 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Padua, Dept Women & Childrens Hlth, Clin Gynecol & Obstet, Padua, Italy
[3] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dipartimento Salute Donna & Bambino & San Pubbl, IRCCS, Rome, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dept Gen Thorac Surg, IRCCS, Rome, Italy
[6] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
[7] Aga Khan Hosp Mombasa, Dept Gynecol & Obstet, Mombasa, Kenya
[8] Caucasus Med Ctr, Dept Gynecol Oncol, Tbilisi, Georgia
[9] David Tvildiani Med Univ, Dept Surg, Tbilisi, Georgia
[10] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
[11] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Hsin Chu Branch, Hsinchu, Taiwan
[12] Univ Manchester, Div Canc Sci, Manchester, England
[13] Houston Methodist Hosp, Dept Obstet & Gynecol, Houston, TX USA
关键词
Ovarian Neoplasms; Surgical Oncology; Lymphatic Metastasis; ASSISTED THORACIC-SURGERY; CYTOREDUCTIVE SURGERY; THORACOSCOPIC SURGERY; RESECTION; CARCINOMA; FEASIBILITY; METASTASIS; DISSECTION; MANAGEMENT; MODERATE;
D O I
10.1136/ijgc-2023-004963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer most commonly presents at advanced stages, and prognosis is influenced by residual disease following cytoreduction. The significance of cardiophrenic lymph node resection at the time of cytoreductive surgery in advanced ovarian cancer remains a topic of debate. Enlarged cardiophrenic lymph nodes are detected through high-resolution imaging; however, the optimal imaging technique in determining feasibility of node resection remains uncertain. Similarly, the impact of excision of cardiophrenic lymph nodes on progression-free and overall survival remains elusive. The indications for resection of cardiophrenic lymph nodes are not addressed in standard ovarian cancer guidelines. Patients with cardiophrenic lymph nodes exceeding 1 cm in size may be considered for resection if complete intra-abdominal cytoreduction is feasible to no gross residual. The surgical approach might be either by open access or by video-assisted thoracoscopic surgery (minimally invasive approach), and major complications following cardiophrenic lymph nodes resection are low. Pathological cardiophrenic lymph nodes are associated with a poorer overall prognosis and can serve as a prognostic parameter; however, the therapeutic benefit of cardiophrenic lymph nodes resection remains inconclusive.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [41] Transdiaphragmatic cardiophrenic lymph node dissection in advanced stage gynecologic cancer
    LaFargue, Christopher
    Liu, Fong
    Randall, Leslie
    Bristow, Robert
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 194 - 195
  • [42] What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival
    Addley, Susan
    Asher, Viren
    Kirke, Rathy
    Bali, Anish
    Abdul, Summi
    Phillips, Andrew
    [J]. EJSO, 2022, 48 (12): : 2531 - 2538
  • [43] How to manage lymph nodes in ovarian cancer
    Harter, Philipp
    Heitz, Florian
    Ataseven, Beyhan
    Schneider, Stephanie
    Baert, Thais
    Prader, Sonia
    du Bois, Andreas
    [J]. CANCER, 2019, 125 : 4573 - 4577
  • [44] Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer
    Park, Kena
    Kwon, Ji Young
    Song, Jeong Min
    Pyeon, Seung Yeon
    Lee, Seon Hwa
    Chung, Young Shin
    Lee, Jong-Min
    Romano, Federico
    Giannini, Andrea
    Giannini, Andrea
    [J]. PLOS ONE, 2024, 19 (05):
  • [45] Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study
    Lopes, Andre
    Rangel Costa, Ronaldo Lucio
    di Paula, Raphael
    Anton, Cristina
    Calheiros, Ytauan
    Sartorelli, Vivian
    Kanashiro, Yara Mitie
    de Lima, Joao Alves
    Yamada, Alayne
    Pinto, Gabriel Lowndes de S.
    Vianna, Maria Regina
    Nogueira Dias Genta, Maria Luiza
    Ribeiro, Ulysses
    dos Santos, Marcelo Oliveira
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) : 188 - 194
  • [46] Cardiophrenic and costophrenic lymphadenectomy in advanced ovarian cancer by prediaphragmatic subxiphoid approach: PS technique
    Stanciu, Paul, I
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (07) : 1103 - 1104
  • [47] Management of retroperitoneal lymph nodes in the treatment of ovarian cancer
    Kimio Ushijima
    [J]. International Journal of Clinical Oncology, 2007, 12 : 181 - 186
  • [48] Management of retroperitoneal lymph nodes in the treatment of ovarian cancer
    Ushijima, Kimio
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (03) : 181 - 186
  • [49] Extrapleural and cardiophrenic lymph nodes: prevalence, clinical significance and diagnostic value
    Beatrice Feragalli
    Cesare Mantini
    Nicoletta Civitareale
    Roberta Polverosi
    Armando Tartaro
    Antonio Raffaele Cotroneo
    [J]. La radiologia medica, 2014, 119 : 20 - 26
  • [50] Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian Cancer
    Keyver-Paik, Mignon-Denise
    Arden, Janne Myriam
    Luders, Christine
    Thiesler, Thore
    Abramian, Alina
    Hoeller, Tobias
    Hecking, Thomas
    Ayub, Tiyasha Hosne
    Doeser, Anna
    Kaiser, Christina
    Kuhn, Walther
    [J]. ANTICANCER RESEARCH, 2016, 36 (04) : 1815 - 1824